Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Simon

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 9, 2011
Crohn's disease recurrence after total proctocolectomy with definitive ileostomyAurélien Amiot, Jean-Marc Gornet, Clotilde Baudry, et al.
Advances in Experimental Medicine and Biology|May 25, 2022
Non-surgical Periodontal Treatment: SRP and Innovative Therapeutic ApproachesAlexia Vinel, Antoine Al Halabi, Sébastien Roumi, et al.
Journal of Crohn'S & Colitis|November 18, 2020
Safety of Hydrocortisone Premedication Discontinuation in Patients with Inflammatory Bowel Disease on Maintenance Therapy with Infliximab: a Prospective Clinical and Pharmacological StudyMy-Linh Tran-Minh, Jean-Marc Gornet, Marianne Maillet, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor AgentsPauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Clinical and Translational Gastroenterology|July 31, 2023
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube DigestifLucas Guillo, Guillaume Savoye, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2018
Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Guillaume Le Baut, Laurent Peyrin-Biroulet, Guillaume Bouguen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015
Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic StricturesMathurin Fumery, Guillaume Pineton de Chambrun, Carmen Stefanescu, et al.
The American Journal of Gastroenterology|November 6, 2020
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAIDConstance Chapuis-Biron, Julien Kirchgesner, Benjamin Pariente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 16, 2022
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAIDAurelien Amiot, Philippe Seksik, Jean-Marie Reimund, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 9, 2011
Crohn's disease recurrence after total proctocolectomy with definitive ileostomyAurélien Amiot, Jean-Marc Gornet, Clotilde Baudry, et al.
Advances in Experimental Medicine and Biology|May 25, 2022
Non-surgical Periodontal Treatment: SRP and Innovative Therapeutic ApproachesAlexia Vinel, Antoine Al Halabi, Sébastien Roumi, et al.
Journal of Crohn'S & Colitis|November 18, 2020
Safety of Hydrocortisone Premedication Discontinuation in Patients with Inflammatory Bowel Disease on Maintenance Therapy with Infliximab: a Prospective Clinical and Pharmacological StudyMy-Linh Tran-Minh, Jean-Marc Gornet, Marianne Maillet, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor AgentsPauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Clinical and Translational Gastroenterology|July 31, 2023
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube DigestifLucas Guillo, Guillaume Savoye, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2018
Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Guillaume Le Baut, Laurent Peyrin-Biroulet, Guillaume Bouguen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015
Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic StricturesMathurin Fumery, Guillaume Pineton de Chambrun, Carmen Stefanescu, et al.
The American Journal of Gastroenterology|November 6, 2020
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAIDConstance Chapuis-Biron, Julien Kirchgesner, Benjamin Pariente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 16, 2022
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAIDAurelien Amiot, Philippe Seksik, Jean-Marie Reimund, et al.
Pageof 3